Arthritis Rheum. 1996 May;39(5):713-22.
RA is a chronic progressive polyarthritis (with varying systemic features) associated with substantial disability and economic losses. Successful treatment to limit joint damage and functional loss requires early diagnosis and timely initiation of disease-modifying agents. The goal of treatment is to arrest the disease and to achieve remission. Although remission rarely occurs, patients may still benefit from pharmacologic, nonpharmacologic, and if necessary, surgical interventions. Optimal longitudinal treatment requires comprehensive coordinated care and the expertise of a number of providers. Essential components of management include 1) establishment of the diagnosis of RA (versus other forms of polyarthritis), 2) systematic and regular evaluation of disease activity, 3) patient education/rehabilitation interventions, and initial treatment with NSAIDs, 4) use of DMARDs, 5) possible use of local or low-dose oral glucocorticoids, 6) minimization of the impact on the individual's function, 7) assessment of the adequacy of the treatment program, and 8) general health maintenance.
类风湿性关节炎(RA)是一种慢性进行性多关节炎(伴有多种全身症状),会导致严重残疾和经济损失。成功治疗以限制关节损伤和功能丧失需要早期诊断并及时启动改善病情的药物。治疗目标是控制疾病并实现缓解。尽管缓解很少发生,但患者仍可能从药物、非药物以及必要时的手术干预中获益。最佳的长期治疗需要全面协调的护理以及多位医疗服务提供者的专业知识。管理的基本要素包括:1)确立类风湿性关节炎的诊断(与其他形式的多关节炎相鉴别),2)对疾病活动进行系统定期评估,3)患者教育/康复干预以及使用非甾体抗炎药进行初始治疗,4)使用改善病情抗风湿药(DMARDs),5)可能使用局部或低剂量口服糖皮质激素,6)将对个体功能的影响降至最低,7)评估治疗方案的充分性,以及8)维持总体健康。